We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

40 hedge funds and large institutions have $124M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

14% more funds holding

Funds holding: 35 → 40 (+5)

11% more capital invested

Capital invested by funds: $112M → $124M (+$12M)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

Holders
40
Holders Change
+5
Holders Change %
+14.29%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LA
Linden Advisors
New York
+$6.79M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
+$4.85M
3
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
+$4.85M
4
CF
Cantor Fitzgerald
New York
+$4.75M
5
Millennium Management
Millennium Management
New York
+$1.32M

Top Sellers

Rank Fund Capital Flow
1
FIG
Fortress Investment Group
New York
-$5.03M
2
SCM
Shaolin Capital Management
Florida
-$2.92M
3
UOC
UBS O'Connor
Illinois
-$2.51M
4
ACA
Arena Capital Advisors
California
-$933K
5
HighTower Advisors
HighTower Advisors
Illinois
-$877K
Name Holding Trade Value Shares
Change 		Change in
Stake
DCM
26
DG Capital Management
New York
$1.25M -$459K -47,335 -27%
CCM
27
Context Capital Management
California
$1.03M +$1.03M +105,800 New
CH
28
CVI Holdings
Delaware
$992K +$16.2K +1,669 +2%
DCM
29
Dupont Capital Management
Delaware
$976K – – –
AFM
30
Anson Funds Management
Texas
$731K – – –
WA
31
Whitebox Advisors
Minnesota
$731K – – –
EAM
32
Exos Asset Management
New York
$514K +$17.1K +1,760 +3%
LOAMU
33
Lombard Odier Asset Management (USA)
New York
$487K – – –
BCM
34
Basso Capital Management
Connecticut
$487K +$485K +50,009 New
Bank of Nova Scotia
35
Bank of Nova Scotia
Ontario, Canada
$390K – – –
FLC
36
Fifth Lane Capital
Texas
$326K – – –
GCL
37
Glazer Capital LLC
New York
$274K +$273K +28,181 New
HF
38
HRT Financial
New York
$195K – – –
WAM
39
Wolverine Asset Management
Illinois
$22K +$22.2K +2,283 New
FIG
40
Fortress Investment Group
New York
– -$5.03M -519,489 Closed
UOC
41
UBS O'Connor
Illinois
– -$2.51M -256,880 Closed
1
2

ORIA Hedge Fund Activity: Q1 2022 in Review

40 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q1 2022, worth a combined $124M — up 11% from $112M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ORIA positions and 3 closed out — a net gain of 5 holders — while 4 added to existing stakes and 7 trimmed.

The largest buyer was Linden Advisors, opening a new position worth an estimated $6.79M. The largest seller was Fortress Investment Group, exiting entirely with an estimated $5.03M sold.

  • 40 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q1 2022, up from 35 in Q4 2021.
  • Funds reported $124M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q1 2022, up 11% quarter-over-quarter.
  • 8 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q1 2022 and 3 closed out, a net change of +5 holders.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q1 2022 was Linden Advisors, an estimated $6.79M added.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q1 2022 was Fortress Investment Group, an estimated $5.03M sold.

Based on aggregated 13F filings for Q1 2022.